Harnessing Optimism and Perseverance in the Face of Long COVID-Español

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIcahn School of Medicine at Mount Sinai

About this trial

The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, and coping skills for those living with chronic Long COVID. HOPE-LC\~Español provides a culturally and linguistically adapted version for Spanish-speaking individuals in Queens, developed with input from Spanish-speaking clinicians, Long COVID experts, and people with lived experience. Partnering with H+H/Elmhurst and H+H/Queens, the project aims to recruit 25 participants and evaluate program feasibility and preliminary efficacy.

Eligibility criteria

Qualifiers

Age 18 years or older.

Speaks and understands Spanish at a level that allows active participation in group-based study procedures.

Self-reported history of Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms affecting daily functioning or a medical professional has diagnosed you with a Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms.

Ability to participate in group sessions either in-person or via telehealth (Zoom).

Disqualifiers

Presence of severe psychiatric conditions that would preclude participation in group therapy (e.g., active psychosis, suicidal intent requiring immediate intervention).

Inability to communicate in Spanish sufficiently to engage meaningfully in group sessions.

Cognitive or physical impairments prevent participation in group sessions or completion of surveys, without available accommodations.

Concurrent participation in another conflicting interventional trial targeting Long COVID symptoms.

Trial design

Treatments tested in this trial

  • HOPE-LC~Espanol

Treatment groups

25 Participants
are divided into 1 treatment group